Results 271 to 280 of about 38,853 (283)
Some of the next articles are maybe not open access.

Cardiac Involvement in β‐Thalassemia Major and β‐Thalassemia Intermedia

Hemoglobin, 2004
The forms and severity of cardiac complications were investigated in patients with asymptomatic thalassemia intermedia and thalassemia major by M-mode, bi-dimensional echocardiography (ECHO) and echo-Doppler. Twenty-eight patients of both sexes with beta-thalassemia intermedia (beta-TI), mean age 23.2 +/- 6.3 years, untransfused or minimally transfused,
Luigi Esposito   +7 more
openaire   +3 more sources

Cognitive deficits in beta-thalassemia major

Acta Neurologica Scandinavica, 2000
To assess cognitive functioning in patients affected by beta-thalassemia major (beta-th) by using a neuropsychological battery, and to identify clinical correlates.Forty-six beta-th patients and 46 controls similar for age, sex, and education participated in the study. All subjects performed a comprehensive neuropsychological battery including tests of
Roberto Monastero   +4 more
openaire   +3 more sources

Schizophrenia and beta-thalassemia: A genetic link?

Psychiatry Research, 2008
This report of two cases in which schizophrenia and beta-thalassemia occurred simultaneously in several family members may suggest that a genetic link exists between these two disorders. A known genetic disease (beta-thalassemia) could help confirm the presence, on the short arm of chromosome 11, of a genetic susceptibility factor for schizophrenia.
Borras, Laurence, Huguelet, Philippe
openaire   +4 more sources

THE BETA-THALASSEMIA [PDF]

open access: possibleScientific Journal of Medical Research, 2017
openaire   +1 more source

ALPHA‐ AND BETA‐THALASSEMIA IN THAILAND*

Annals of the New York Academy of Sciences, 1969
S. Pootrakul   +6 more
openaire   +3 more sources

In Brief: Casgevy for Beta Thalassemia

The Medical Letter on Drugs and Therapeutics
Exagamglogene autotemcel (Casgevy – Vertex), a cell-based gene therapy recently approved for treatment of sickle cell disease1, has now been approved by the FDA for treatment of patients ≥12 years old with transfusion-dependent beta thalassemia.
openaire   +2 more sources

Breathless: Beta Thalassemia Major

The American Journal of Medicine, 2017
Vassiliki Katsi   +3 more
openaire   +3 more sources

HEMOGLOBIN SYNTHESIS IN BETA‐THALASSEMIA

Annals of the New York Academy of Sciences, 1969
A. M. Benson, E. R. Huehns, C. B. Modell
openaire   +3 more sources

Beta-thalassemia and proteolysis. Proteolysis of excess alpha-chains in beta-thalassemia.

The Journal of laboratory and clinical medicine, 1982
Edward R. Burka, Samir K. Ballas
openaire   +3 more sources

THE BETA‐DELTA THALASSEMIASs1

Annals of the New York Academy of Sciences, 1969
T Papayannopoulou   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy